Néo Psychikó (GR)
{name}
{subtitle}
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~5 mi. (Athens, Greece, +192 more cities)
facility
Alexandra Hospital, +1 more facility
biomarker
ER Positive, +1 more biomarker
condition
Breast Carcinoma
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~5 mi. (Athens, Greece, +176 more cities)
facility
Perifereiako Geniko Nosokomeio ALEXANDRA ( Site 2425), +1 more facility
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~5 mi. (Athens, Greece, +89 more cities)
facility
Alexandra Hospital-ONCOLGOY DEPT. ( Site 0302)
biomarker
ER Positive, +2 more biomarkers
condition
Breast Carcinoma
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~5 mi. (Athens, Greece, +147 more cities)
facility
Alexandra General Hospital ( Site 0477)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
city
~5 mi. (Athens, Greece, +93 more cities)
facility
General Hospital of Athens "Alexandra" ( Site 0303)
condition
Bladder Carcinoma, +1 more condition
drug
cisplatin, +4 more drugs
drug type
chemotherapy, +3 more types
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
city
~5 mi. (Athens, Greece, +122 more cities)
facility
Sotiria Regional Chest Diseases Hospital of Athens ( Site 1200)
condition
Small Cell Lung Carcinoma
drug
etoposide, +5 more drugs
drug type
chemotherapy, +3 more types
Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)
city
~5 mi. (Athens, Greece, +137 more cities)
facility
Andreas Syggros Hospital ( Site 0450)
condition
Skin Squamous Cell Carcinoma
drug
pembrolizumab
drug type
immunotherapy
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~5 mi. (Athens, Greece, +127 more cities)
facility
General Hospital of Athens Evangelismos /ID# 238810, +1 more facility
condition
Acute Myeloid Leukemia
drug
azacitidine, +2 more drugs
drug type
chemotherapy